Treffer: The use of fully immersive virtual reality for screening neurodegenerative diseases

Title:
The use of fully immersive virtual reality for screening neurodegenerative diseases
Publisher Information:
Elsevier
Publication Year:
2026
Collection:
University of Kent: KAR - Kent Academic Repository
Document Type:
Fachzeitschrift article in journal/newspaper
File Description:
application/pdf
Language:
English
Relation:
https://kar.kent.ac.uk/112338/11/Alz%20%20%20Dem%20Diag%20Ass%20%20%20Dis%20Mo%20-%202026%20-%20Liu%20-%20The%20use%20of%20fully%20immersive%20virtual%20reality%20for%20screening%20neurodegenerative.pdf; https://kar.kent.ac.uk/112338/1/Manuscript_EFR.pdf; Liu, Zhao, Soria, Daniele, Jie, Daniel Lai, Zhang, Jinbao, Shergill, Sukhi, Ang, Chee Siang (2026) The use of fully immersive virtual reality for screening neurodegenerative diseases. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 18 (1). Article Number e70244. ISSN 2352-8729. (doi:10.1002/dad2.70244 ) (KAR id:112338 )
DOI:
10.1002/dad2.70244
Rights:
cc_by
Accession Number:
edsbas.D5B93137
Database:
BASE

Weitere Informationen

Early detection of Alzheimer's disease (AD), Parkinson's disease (PD), and mild cognitive impairment (MCI) is crucial for timely intervention. Traditional cognitive screening tools lack ecological validity and sensitivity. Virtual reality (VR) provides realistic, controlled environments for assessing multidimensional cognition. This systematic review evaluated the diagnostic accuracy, feasibility, and applicability of immersive VR assessments for neurodegenerative screening. We searched PubMed, PsycINFO, and Embase for studies published June 2005 to April 2024. Eligible studies used head-mounted displays in adults with MCI, early AD/PD, or dementia. Ten studies (n = 472) met criteria. Tasks targeted spatial memory, executive function, attention, and navigation. Several reported strong discriminations (area under the curve up to 0.89) and, when combined with machine learning, accuracies of 87% to 100%. Immersive VR shows promise as an ecologically valid, engaging, and scalable screening approach; however, standardization of tasks and outcomes, real-world validation, and robust longitudinal evidence are needed to support clinical adoption. Highlights This review systematically describes the application of fully immersive virtual reality (VR) in the early screening of neurodegenerative diseases, with a focus on studies using head-mounted devices to simulate real-life tasks. Task types such as spatial memory, daily living simulations, and executive function assessments have demonstrated high sensitivity and specificity in diagnosing mild cognitive impairment (MCI) and early-stage Alzheimer's disease (AD). Approximately one third of studies combined machine learning techniques to analyze multimodal behavioral data (e.g., path deviations, task duration, and language responses), significantly improving diagnostic accuracy. This study highlights methodological heterogeneity, small sample sizes, and the lack of longitudinal studies as current research limitations, and calls for future standardized, multicenter, and ...